Mood Disorders Now Qualify for COVID Boosters; Shortages of psychiatric beds; Sad vegans?


The CDC added mood disorders, including depression and schizophrenia, to the list of underlying conditions eligible for COVID-19 booster injections. (Washington post)

New from New Hampshire Psychiatric hospital for inpatients with 111 beds will also include a unit dedicated to young adults up to 25 years old. (American News and World Report)

Extensive post-market analysis of 15 mono-treated antidepressants prescribed to over 3 million patients with major depression found that even the best antidepressant only had an average remission rate of 50.78%. (EClinicalMedicine)

Georgia is one of many states facing a grave shortage of psychiatric hospital beds. (News from Kaiser Santé)

Mirtazapine (Remeron) used for agitation in patients with dementia was not more effective than placebo, and also resulted in a higher incidence of death. “This study shows that a common way of managing symptoms is not helpful – and could even be detrimental. It is really important that these findings are taken into account and mirtazapine is no longer used to treat agitation in people. people with dementia, ”said the study’s author. Sube Banerjee, MD, of the University of Plymouth in England, in a statement. (The Lancet)

Long-term survivors of childhood cancer appeared to be at a slightly higher risk of suicide after the age of 28 – especially for male patients. (Cancer)

A meta-analysis funded by the National Cattlemen’s Beef Association found that meat consumption was linked to a lower risk of depression and anxiety compared to a vegan diet. (Critical opinions in food science and nutrition)

Boehringer Ingelheim announced a new collaboration with the Institute of Psychiatry, Psychology & Neuroscience at King’s College London to study brain patterns and cognition in people with depression and schizophrenia.

Irwin Marcus, renowned psychiatrist from New Orleans, MD, passed away earlier this month at the age of 102. He established the Child and Adolescent Psychiatry Program at Tulane University School of Medicine in 1952 and was the founder and president of the New Orleans Psychoanalytic Institute. (

  • Kristen Monaco is editor-in-chief, specializing in news in endocrinology, psychiatry and nephrology. Based in the New York office, she has been with the company since 2015.


Comments are closed.